A Phase II Dose-ranging Study of Oral RV3-BB Rotavirus Vaccine
Clinical trial NCT03483116 · COMPLETED
Trial details
- NCT number
- NCT03483116
- Sponsor
- Murdoch Childrens Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-15
- Primary completion
- 2020-01-27
- Enrollment
- 711
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.